Esophageal candidiasis: Difference between revisions

(Text replacement - "* " to "*")
No edit summary
Line 3: Line 3:


==Clinical Features<ref name=candida>Kauffmann CA. Overview of Candida Infections. UptoDate. 2016.</ref>==
==Clinical Features<ref name=candida>Kauffmann CA. Overview of Candida Infections. UptoDate. 2016.</ref>==
*odynophagia
*Odynophagia
*dysphagia
*[[Dysphagia]]
*retrosternal pain
*[[Chest pain|Retrosternal pain]]
*[[nausea/vomiting]]
*[[Nausea/vomiting]]


==Differential Diagnosis==
==Differential Diagnosis==
===[[Esophagitis]]===
===[[Esophagitis]]===
*Esophageal candidiasis
*[[Esophageal candidiasis]]
*Cytomegalovirus esophagitis  
*[[CMV esophagitis]]
*Herpes Simplex esophagitis  
*[[HSV]] esophagitis  
*Eosinophilic esophagitis
*Eosinophilic esophagitis
*Medication-induced esophagitis
*Medication-induced esophagitis

Revision as of 20:34, 29 September 2019

Background

  • Most commonly seen in HIV patients with CD4 count < 100 (AIDS-defining illness) or chronic inhaled glucocorticoid use

Clinical Features[1]

Differential Diagnosis

Esophagitis

Evaluation

Esophageal Candidiasis
  • Thick, white, linear esophageal plaques on endoscopy

Management

  • Fluconazole 400mg PO loading dose, followed by 200mg PO Qdaily x 2 weeks
  • Itraconazole 200mg PO Qdaily for 2 weeks
    • has more nausea side-effects and drug interactions compared to fluconazole

Disposition

See Also

External Links

References

  1. Kauffmann CA. Overview of Candida Infections. UptoDate. 2016.